Yihua Zhao

Efficacy and safety of the novel glycine transporter inhibitor BI 425809 once daily in patients with schizophrenia: a double-blind, randomised, placebo-controlled phase 2 study

W. Wolfgang Fleischhacker, Jana Podhorná, Martina Gröschl et al. · The Lancet Psychiatry · 2021 · 124 citations

Placebo-controlled Phase 2, Psychiatry, Pharmacology +6

Phase I Open-Label Study of Continuous Treatment with BIBF 1120, a Triple Angiokinase Inhibitor, and Pemetrexed in Pretreated Non–Small Cell Lung Cancer Patients

Peter Ellis, R. Kaiser, Yihua Zhao et al. · Clinical Cancer Research · 2010 · 96 citations · Full text

A Phase I, open-label, dose-escalation study of continuous once-daily oral treatment with afatinib in patients with advanced solid tumors

Michael S. Gordon, David S. Mendelson, Mitchell E. Gross et al. · Investigational New Drugs · 2012 · 36 citations · Full text

Obesity and cardiovascular thrombotic events in patients undergoing percutaneous coronary intervention with drug-eluting stents

Zhiru Wang, Yuan Zhou, Yang Liu et al. · Heart · 2009 · 34 citations

Effect of 12 weeks of once-daily tiotropium/olodaterol on exercise endurance during constant work-rate cycling and endurance shuttle walking in chronic obstructive pulmonary disease

François Maltais, Denis E. O’Donnell, Juan Bautista Gáldiz Iturri et al. · Therapeutic Advances in Respiratory Disease · 2018 · 34 citations · Full text